NIKKEI 225
38,069.20 +107.40 (+0.28%) HANG SENG
16,469.29 +217.45 (+1.34%) CRUDE OIL
82.82 +0.13 (+0.16%) GOLD FUTURES
2,390.20 +1.80 (+0.08%) DOW
37,753.31 -45.66 (-0.12%) Bitcoin GBP
49,500.23 -1,985.14 (-3.86%)
Oxford BioDynamics Plc (OBD.L)
- Simply Wall St.
Is Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Business Wire
Bupa UK to cover EpiSwitch® CiRT for customers with cancer
OXFORD, England, October 18, 2023--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform and Bupa, the UK’s leading health insurer, announce a strategic agreement to give Bupa patients access to OBD’s EpiSwitch CiRT (Checkpoint inhibitor Response Test).
- Business Wire
Oxford BioDynamics Receives Reimbursement Code for EpiSwitch® Prostate Screening (PSE) Test
OXFORD, England, October 03, 2023--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform, confirms the assignment and publication of a Proprietary Laboratory Analysis Code (PLA Code) by the American Medical Association’s CPT (Current Procedural Terminology) Editorial Board (https://www.ama-assn.org/practice-management/cpt/cpt-pla-codes).
